Deep vein thrombosis prophylaxis after total-knee arthroplasty

Current Opinion in Orthopaedics

Volumn 17, Issue 1, 2006, Pages 60-67

  Boscainos, Petros J ^a   McLardy Smith, Peter ^a   Jinnah, Riyaz H ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

Deep vein thrombosis; Prevention; Thromboembolic disease; Total knee arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; WARFARIN; XIMELAGATRAN;

ANESTHESIA; BLEEDING; CHRONIC VEIN INSUFFICIENCY; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG HYPERSENSITIVITY; HOSPITALIZATION; HUMAN; INCIDENCE; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LEG PHLEBOGRAPHY; LIFESTYLE; LUNG EMBOLISM; PEPTIC ULCER; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSTHESIS; PROTECTIVE CLOTHING; RECURRENT DISEASE; SURGICAL RISK; THROMBOCYTOPENIA; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TOURNIQUET; VENA CAVA FILTER;

EID: 33645101032     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bco.0000192520.48411.fa     Document Type: Conference Paper

References (78)

1. Cohen SH, Ehrlich GE, Kauffman MS, et al. Thrombophlebitis following knee surgery. J Bone Joint Surg Am 1973; 55:106-112.
2. Kim Y-H, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective randomised study. J Bone Joint Surg Br 2002; 84:566-570.
3. Haas SB, Tribus CB, Insall JN, et al. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg Br 1992; 74:799-802.
4. Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med 1999; 159:445-453.
5. McNally MA, Bahadur R, Cooke EA, Mollan RA. Venous hemodynamics in both legs after total knee replacement. J Bone Joint Surg 1997; 79B:633-637.
6. Dahl EO, Molnar I, Ro JS, Vinje A. Global tests on coagulation and fibrinolysis in systemic and pulmonary circulation accompanying hip arthroplasty with acrylic cement. Thromb Res 1988; 50:865-873.
7. Bergqvist D, Benoni G, Bjorgell O, et al. Low molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335:696-700.
8. Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison enoxaparin versus placebo. Lancet 1996; 348:224-228.
9. Anderson DR, Gross M, Robinson S, et al. Ultrasonographic screening for deep vein thrombosis following arthroplasty fails to reduce posthospital thromboembolic complications. Chest 1998; 114:119S-122S.
10. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Sixth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Chest 2001; 119:132S-175S.
11. Fitzgerald RH Jr, Spiro TE, Trowbridge AA, et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 2001; 83:900-906.
12. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg 1984; 66A:194-201.
13. Colwell CW Jr, Spiro TE, Trowbridge AA, et al. Efficacy and safety of enoxaparin versus unfractioned heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group. Clin Orthop Relat Res 1995; 321:19-27.
14. Grady-Benson JC, Oishi CS, Hanson PB, et al. Post-operative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty. J Bone Joint Surg Am 1994; 76:1649-1657.
15. Haas SB, Insall JN, Scuderi GR, et al. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am 1990; 72:27-31.
16. Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329:1370-1376.
17. Kaempffe FA, Lifeso RM, Meinking C. Intermittent pneumatic compression versus coumadin. Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop Relat Res 1991; 269:89-97.
18. Khaw FM, Moran CG, Pinder IM, Smith SR. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation. J Bone Joint Surg Br 1993; 75:940-941.
19. Douketis JD, Eikelboom JW, Quinlan DJ, et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162:1465-1471.
20. Eikelboom JW, Quinlan DJ, Douketis JD. Extended duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 2001; 358:9-15.
21. Samana MM. An epidemiological study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160:3415-3420.
22. Wahlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 2002; 87:580-585.
23. Ferrari E, Chevallier T, Chapelier A, Baudouy M. Travel as a risk factor for venous thromboembolic disease: a case-control study. Chest 1999; 115:440-444.
24. Kelman CW, Kortt MA, Becker NG, et al. Deep vein thrombosis and air travel:record linkage study. BMJ 2003; 327:1072-1075.
25. Nielsen PT, Jorgensen LN, Albrecht-Beste, et al. Lower thrombosis risk with epidural blockade in knee arthroplasty. Acta Orthop Scand 1990; 61:29-31.
26. Williams-Russo P, Sharrock NE, Haas SB, et al. Randomized trial of epidural versus general anesthesia outcomes after primary total knee replacement. Clin Orthop Relat Res 1996; 331:199-208.
27. Jørgensen LN, Lind B, Hauch O, et al. Thrombin-antithrombin III-complex & fibrin degradation products in plasma: Surgery and postoperative deep venous thrombosis. Thromb Res 1990; 59:69-76.
28. Mitchell D, Friedman RJ, Baker JD 3rd, et al. Prevention of thromboembolic disease following total knee arthroplasty. Epidural versus general anesthesia. Clin Orthop Relat Res 1991; 269:109-112.
29. Sharrock NE, Haas SB, Hargett MJ, et al. Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am 1991; 73:502-506.
30. Lieberman JR, Huo MM, Hanway J, et al. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg Am 1994; 76:341-348.
31. Haas SB. Effects of epidural anesthesia on incidence of venous thromboembolism following joint replacement. Orthopedics 1994; 17S:18-20.
32. Sharrock NE, Go G, Williams-Russo P, et al. Comparison of extradural and general anaesthesia on the fibrinolytic response to total knee arthroplasty. Br J Anaesth 1997; 79:29-34.
33. Aglietti P, Baldini A, Vena LM, et al. Effect of tourniquet use on activation of coagulation in total knee replacement. Clin Orthop Relat Res 2000; 371:169-177.
34. Sharrock NE, Hargett MJ, Urquhart B, et al. Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty 1993; 8:133-139.
35. Wauke K, Nagashima M, Kato N, et al. Comparative study between thromboembolism and total knee arthroplasty with or without tourniquet in rheumatoid arthritis patients. Arch Orthop Trauma Surg 2002; 122:442-446.
36. Parmet JL, Berman AT, Horrow JC, et al. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet 1993; 341:1057-1058.
37. Dahl AE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000; 71:47-50.
38. Clarke MT, Green JS, Harper WM, Gregg PJ. Cement as a risk factor for deep-vein thrombosis. Comparison of cemented TKR, uncemented TKR and cemented THR. J Bone Joint Surg Br 1998; 80:611-613.
39. Kim Y-H. The incidence of deep vein thrombosis after cementless and cemented knee replacements. J Bone Joint Surg Br 1990; 72:779-783.
40. Westrich GH, Menezes A, Sharrock N, Sculco TP. Thromboembolic disease prophylaxis in total knee arthroplasty using intraoperative heparin and post-operative pneumatic foot compression. J Arthroplasty 1999; 14:651-656.
41. Brookenthal KR, Freedman KB, Lotke PA, et al. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001; 16:293-300.
42. Bottner F, Sculco TP. Nonpharmacologic thromboembolic prophylaxis in total knee arthroplasty. Clin Orthop Relat Res 2001; 392:249-256.
43. Giachino AA, Rody K, Turek MA, et al. Systemic fat and thrombus embolization in patients undergoing total knee arthroplasty with regional heparinization. J Arthroplasty 2001; 16:288-292.
44. Iobst CA, Friedman RJ. The role of low molecular weight heparin in total knee arthroplasty. Am J Knee Surg 1999; 12:55-60.
45. Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345:1305-1310.
46. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopaedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162:1833-1840.
47. Eriksson BI, Bergqvist D, Kalebo P, et al. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomized trial. Lancet 2002; 360:1441-1447.
48. Eriksson BI, Agnelli G, Cohen AT, et al. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost 2003; 89:288-296.
49. Heit JA, Colwell CW, Francis CW, et al. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. Arch Intern Med 2001; 161:2215-2221.
50. van Dongen CJ, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev 2003; 1 [CD0003074].
51. Howard AW, Aaron SD. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials. Thromb Haemost 1998; 79:902-906.
52. Heit JA, Elliott CG, Trowbridge AA, et al. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 132:853-861.
53. Francis CW, Marder VJ, Evarts CM, et al. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. JAMA 1983; 249:374-378.
54. Lieberman JR. Warfarin prophylaxis after total knee arthroplasty. Am J Knee Surg 1999; 12:49-53.
55. Lieberman JR, Sung R, Dorey F, et al. Low-dose warfarin prophylaxis to prevent symptomatic pulmonary embolism after total knee arthroplasty. J Arthroplasty 1998; 12:180-184.
56. Robinson KS, Anderson DR, Gross M, et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med 1997; 127:439-445.
57. Fitzgerald RH Jr. Preventing DVT following total knee replacement: a review of recent clinical trials. Orthopedics 1995; 18S:10-11.
58. Francis CW, Berkowitz SD, Comp PC, et al. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 2003; 349:1703-1712.
59. Francis CW, Davidson BL, Berkowitz SD, et al. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. Ann Intern Med 2002; 137:648-655.
60. Benko T, Cooke EA, McNally MA, Mollan RA. Graduated compression stockings: knee length or thigh length. Clin Orthop Relat Res 2001; 383:197-203.
61. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000; 3 [CD001484].
62. Hui AC, Heras-Palou C, Dunn I, et al. Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement. J Bone Joint Surg Br 1996; 78:550-554.
63. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am 1996; 78:826-834.
64. Blanchard J, Meuwly JY, Leyvraz PF, et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999; 81:654-659.
65. Warwick D, Harrison J, Whitehouse S, et al. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement. J Bone Joint Surg Br 2002; 84:344-350.
66. Wilson NV, Das SK, Kakkar VV, et al. Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V Impulse System. J Bone Joint Surg Br 1992; 74:50-52.
67. Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:401S-428S. The seventh update of the consensus of the American College of Chest Physicians on antithrombotic treatment.
68. Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br 2000; 82:795-800.
69. Tamir L, Hendel D, Neyman C, et al. Sequential foot compression reduces lower limb swelling and pain after total knee arthroplasty. J Arthroplasty 1999; 14:333-338.
70. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br 2004; 86:809-812. A randomized controlled trial demonstrating the efficacy of the combination of LMWH with pneumatic compression in the prevention of DVT in the early post-operative period.
71. Fuchs S, Heyse T, Rudofsky G, et al. Continuous passive motion in the prevention of deep-vein thrombosis: a randomised comparison in trauma patients. J Bone Joint Surg Br 2005; 87:1117-1122.
72. Berry DJ. Surveillance for venous thromboembolic disease after total knee arthroplasty. Clin Orthop Relat Res 2001; 392:257-266.
73. Leclerc JR, Gent M, Hirst J, et al. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med 1998; 158:873-878.
74. Schmidt B, Michler R, Klein M. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopaedic surgery. A randomized controlled trial. Thromb Haemost 2003; 90:949-954.
75. Fancher TL, White RH, Kravitz RL. Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review. BMJ 2004; 329:821-824.
76. Miric A, Lombardi P, Sculco TP. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Am J Orthop 2000; 29:269-274.
77. Sculco TP. Establishing a universal protocol for deep vein thrombosis following orthopaedic surgery. Orthopedics 1996; 19S:6-8.
78. Booth RE Jr. Critical care pathways in thromboembolic disease. Orthopaedics 1995; 18:6S-9S.